SCHEMBL24435692

SCHEMBL24435692

CNc1nc(Nc2cn(C3CC3(C)C)nc2C2CC2)ncc1C(F)(F)F

nearest known ligand 0.63

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 20/20 0.63
CYP1A2 P05177 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22006483 1.00 LRRK2 (0.63) LRRK2CYP1A2
SCHEMBL22006028 0.90 LRRK2 (0.66) LRRK2
SCHEMBL24435695 0.90 LRRK2 (0.66) LRRK2
SCHEMBL22006135 0.89 LRRK2 (0.58) LRRK2CYP1A2
SCHEMBL24435734 0.89 LRRK2 (0.58) LRRK2CYP1A2
SCHEMBL22006484 0.89 LRRK2 (0.58) LRRK2CYP1A2
SCHEMBL22006131 0.89 LRRK2 (0.58) LRRK2CYP1A2
SCHEMBL24435717 0.87 LRRK2 (0.67) LRRK2CYP1A2
SCHEMBL24435751 0.87 LRRK2 (0.67) LRRK2CYP1A2
SCHEMBL24400072 0.85 LRRK2 (0.67) LRRK2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220153728-A1 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. (US) 2022-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153728-A1 COMPOUNDS, COMPOSITIONS AND METHODS LRRK2, SNCA, GSK3B LRRK2 1/4885CYP1A2 4556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.